Search Within

Advanced Practice Providers

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (126)
  2. Journal Article (123)
  3. Research Letter (6)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Biostatistics Service (257)
  2. Epidemiology and Biostatistics (257)
  3. Nursing (209)
  4. Department of Medicine (200)
  5. Survivorship Research (151)
  6. Hematologic Malignancies, Division of (124)

More Groups

People
  1. Sean Devlin (68)
  2. Sergio Giralt (57)
  3. Miguel-Angel Perales (52)
  4. Gunjan Shah (42)
  5. Craig Sauter (32)
  6. Michael Scordo (31)

More People

Years
  1. 2025 (3)
  2. 2024 (15)
  3. 2023 (16)
  4. 2022 (18)
  5. 2021 (24)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (46)
  2. Blood (44)
  3. Biology of Blood and Marrow Transplantation (19)
  4. Annals of Surgical Oncology (8)
  5. Bone Marrow Transplantation (8)
  6. Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (52)
  2. American Society of Hematology (49)
  3. Elsevier Inc. (42)
  4. American Association for Cancer Research (13)
  5. Nature Publishing Group (13)
  6. Springer (13)

More Publishers

Results (257)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Early intervention with telephone triage influences patient outcomes
    Meeting Abstract

    Law, E.; Ginex, P.; Baldwin-Medsker, A.; Tan, K. S.
    Oncology Nursing Forum (2017)

    Fulltext@MSK | Save
  • Prospective evaluation of unrelated donor cord blood and haploidentical donor access reveals graft availability varies by patient ancestry: Practical implications for donor selection
    Journal Article

    Kosuri, S.; Wolff, T.; Devlin, S. M.; Byam, C.; Mazis, C. M.; Naputo, K.; Davis, E.; Paulson, J.; Nhaissi, M.; Wells, D. S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
    Journal Article

    Osorio, J. C.; Ni, A.; Chaft, J. E.; Pollina, R.; Kasler, M. K.; Stephens, D.; Rodriguez, C.; Cambridge, L.; Rizvi, H.; Wolchok, J. D.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Meeting Abstract

    Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP)
    Meeting Abstract

    Shoushtari, A. N.; Navid-Azarbaijani, P.; Friedman, C. F.; Panageas, K.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Campbell, S. C.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma
    Meeting Abstract

    Shoushtari, A. N.; Kudchadkar, R. R.; Panageas, K.; Murthy, R. K.; Jung, M.; Shah, R.; O'Donnell, B.; Khawaja, T. T.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Journal Article

    Shah, G. L.; Yahalom, J.; Matasar, M. J.; Verwys, S. L.; Goldman, D. A.; Bantilan, K. S.; Zhang, Z.; McCall, S. J.; Moskowitz, A. J.; Moskowitz, C. H.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schòˆder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save